Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · IEX Real-Time Price · USD
3.080
0.00 (0.00%)
Jul 22, 2024, 10:20 AM EDT - Market open
Harvard Bioscience Employees
As of December 31, 2023, Harvard Bioscience had 416 total employees, including 391 full-time and 25 part-time employees. The number of employees decreased by 39 or -8.57% compared to the previous year.
Employees
416
Change (1Y)
-39
Growth (1Y)
-8.57%
Revenue / Employee
$256,700
Profits / Employee
-$20,988
Market Cap
133.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Veru Inc. | 189 |
Electromed | 170 |
Inventiva | 123 |
X4 Pharmaceuticals | 93 |
Immunic | 77 |
Compass Therapeutics | 32 |
Corvus Pharmaceuticals | 28 |
CervoMed | 8 |
HBIO News
- 6 weeks ago - Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 - GlobeNewsWire
- 2 months ago - Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 - GlobeNewsWire
- 2 months ago - Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference - GlobeNewsWire
- 2 months ago - Harvard Bioscience Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET - GlobeNewsWire
- 3 months ago - Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth - GlobeNewsWire
- 4 months ago - Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference - GlobeNewsWire
- 4 months ago - Harvard Bioscience Announces Fourth Quarter 2023 Financial Results - GlobeNewsWire